Recently, Bedo Finance learned that Sanovia Technology (Beijing) Co., Ltd. (hereinafter referred to as "Sanovia") reached a counseling agreement with CITIC Construction Investment Securities for the initial public offering and listing in September 2021, and filed it with the Beijing Securities Regulatory Bureau.
It is understood that the listing location planned by Sanovia is the Shanghai Stock Exchange Science and Technology Innovation Board. According to the guidance plan, CITIC Construction Investment Securities will provide guidance to Sanovia, including its directors, supervisors, senior management, shareholders holding more than 5% and actual controllers (legal representatives), etc.
At the same time, CITIC Construction Investment Securities will promote SanoVIC to establish good corporate governance and form the ability to operate independently and develop independently, including assisting and urging SanoVIC to achieve independent operations, ensuring independent and complete business, assets, personnel, finance, and institutions, outstanding main business, and forming core competitiveness.
According to public information, SanoVISA is a high-end X-ray medical imaging equipment research and development, production and sales company, providing products and services including X-ray computer tomography devices, sROBOT robot CT navigation systems, sAI intelligent imaging solutions and other products and services.
Qichacha shows that Sanovia was established in 2012 with a registered capital of 93.439516 million yuan, and the legal representative is Ju Xiaoping. Since its establishment, SanoVisit has received 7 rounds of financing, including Chende Capital, Huagai Capital, Qiming Venture Capital, Shenzhen Venture Capital, etc.
Among them, Ju Xiaoping is an angel investor of Sanovia, with a shareholding ratio of 19.32%. In contrast, management teams such as Sanovia founder and CEO Fu Shinong hold 27.31% of the shares through Beijing Dongxuan Medical Technology Partnership (Limited Partnership).
Sanovia declared that with the mission of "creating industry-leading high-end medical products and providing people-oriented innovative medical services", it has laid out the precision tumor diagnosis and treatment and medical imaging industry chain, and launched three product lines: wide-angle large-aperture high-end CT medical imaging equipment, medical robots, and artificial intelligence imaging solutions.
According to the introduction, Sanovia's CT equipment has been installed in a large number of large comprehensive tertiary hospitals such as Peking Union Medical College and Beijing Tiantan Hospital affiliated to Capital Medical University, and its end users are spread across more than 30 countries or regions with more than 400 medical institutions around the world.
In April 2021, Sanovia also settled in the Longtou Houde Manufacturing Center in Yangzhou, with a planned total investment of 600 million yuan. It will build a world-leading large-scale medical imaging equipment production and manufacturing center in Jiangdu District, and carry out the research and development and manufacturing of a series of innovative products including high-end medical imaging equipment and core components, medical robots, intelligent imaging cloud platforms, etc. After
is put into production, the base can form a production capacity of 800 CT equipment per year.
